Hubbell Inc (HUBB)vsVertex Pharmaceuticals Inc (VRTX)
HUBB
Hubbell Inc
$490.16
-0.49%
INDUSTRIALS · Cap: $25.90B
VRTX
Vertex Pharmaceuticals Inc
$448.29
+3.01%
HEALTHCARE · Cap: $107.87B
Smart Verdict
WallStSmart Research — data-driven comparison
Vertex Pharmaceuticals Inc generates 104% more annual revenue ($12.22B vs $6.00B). VRTX leads profitability with a 35.5% profit margin vs 15.1%. VRTX appears more attractively valued with a PEG of 2.10. VRTX earns a higher WallStSmart Score of 66/100 (B-).
HUBB
Buy62
out of 100
Grade: C+
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-68.2%
Fair Value
$306.75
Current Price
$490.16
$183.41 premium
Margin of Safety
+56.6%
Fair Value
$989.67
Current Price
$448.29
$541.38 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 26 in profit
Keeps 36 of every $100 in revenue as profit
Strong operational efficiency at 38.1%
Earnings expanding 61.4% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 24 in profit
Areas to Watch
Expensive relative to growth rate
Moderate valuation
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : HUBB
The strongest argument for HUBB centers on Return on Equity. Profitability is solid with margins at 15.1% and operating margin at 17.7%. Revenue growth of 11.1% demonstrates continued momentum.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, EPS Growth. Profitability is solid with margins at 35.5% and operating margin at 38.1%.
Bear Case : HUBB
The primary concerns for HUBB are PEG Ratio, P/E Ratio.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
HUBB carries more volatility with a beta of 0.95 — expect wider price swings.
HUBB is growing revenue faster at 11.1% — sustainability is the question.
VRTX generates stronger free cash flow (1.3B), providing more financial flexibility.
Monitor ELECTRICAL EQUIPMENT & PARTS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
VRTX scores higher overall (66/100 vs 62/100), backed by strong 35.5% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Hubbell Inc
INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA
Hubbell Incorporated designs, manufactures, and sells electrical and electronic products in the United States and internationally. The company is headquartered in Shelton, Connecticut.
Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other ELECTRICAL EQUIPMENT & PARTS Stocks
Want to dig deeper into these stocks?